Swiss National Bank Bristol Myers Squibb CO Transaction History

Swiss National Bank

$143 Billion
Q2 2024

A detailed history of Swiss National Bank transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Swiss National Bank holds 6,000,800 shares of BMY stock, worth $319 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares

6,000,800

Previous 6,093,500 1.52%

Holding current value

$319 Million

Previous $330 Million 24.58%

% of portfolio

0.17%

Previous 0.24%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	SELL	$40.25 - $52.99 $3.73 Million - $4.91 Million	-92,700 Reduced 1.52%	6,000,800 $249 Million
Q1 2024 May 07, 2024	SELL	$47.98 - $54.4 $21.1 Million - $23.9 Million	-439,100 Reduced 6.72%	6,093,500 $330 Million
Q4 2023 Feb 06, 2024	SELL	$48.48 - $57.85 $10.9 Million - $13 Million	-224,700 Reduced 3.33%	6,532,600 $335 Million
Q3 2023 Nov 08, 2023	SELL	$57.89 - $64.73 $48.6 Million - $54.3 Million	-839,100 Reduced 11.05%	6,757,300 $392 Million
Q2 2023 Aug 09, 2023	SELL	$63.71 - $70.74 $53.6 Million - $59.5 Million	-841,500 Reduced 9.97%	7,596,400 $486 Million
Q1 2023 May 10, 2023	SELL	$65.71 - $74.53 $15.8 Million - $17.9 Million	-240,400 Reduced 2.77%	8,437,900 $585 Million
Q4 2022 Feb 08, 2023	SELL	$68.48 - $81.09 $37.6 Million - $44.5 Million	-548,557 Reduced 5.95%	8,678,300 $624 Million
Q3 2022 Nov 09, 2022	SELL	$0.13 - $76.84 $29,692 - $17.6 Million	-228,400 Reduced 2.42%	9,226,857 $656 Million
Q2 2022 Aug 09, 2022	SELL	$72.62 - $79.98 $11.5 Million - $12.7 Million	-158,600 Reduced 1.65%	9,455,257 $728 Million
Q1 2022 May 09, 2022	BUY	$61.48 - $73.72 $71.8 Million - $86.1 Million	1,167,700 Added 13.83%	9,613,857 $702 Million
Q4 2021 Feb 08, 2022	SELL	$53.63 - $62.52 $20.8 Million - $24.2 Million	-387,000 Reduced 4.38%	8,446,157 $527 Million
Q3 2021 Nov 08, 2021	SELL	$59.17 - $69.31 $17.9 Million - $21 Million	-302,600 Reduced 3.31%	8,833,157 $523 Million
Q2 2021 Aug 06, 2021	BUY	$61.91 - $67.42 $20.5 Million - $22.4 Million	331,869 Added 3.77%	9,135,757 $610 Million
Q1 2021 May 07, 2021	BUY	$59.34 - $66.74 $10.7 Million - $12 Million	180,500 Added 2.09%	8,803,888 $556 Million
Q4 2020 Feb 05, 2021	SELL	$57.74 - $65.43 $17 Million - $19.2 Million	-293,700 Reduced 3.29%	8,623,388 $535 Million
Q3 2020 Nov 09, 2020	SELL	$57.43 - $63.64 $6.94 Million - $7.69 Million	-120,900 Reduced 1.34%	8,917,088 $538 Million
Q2 2020 Aug 05, 2020	SELL	$54.82 - $64.09 $9.63 Million - $11.3 Million	-175,600 Reduced 1.91%	9,037,988 $531 Million
Q1 2020 May 08, 2020	BUY	$46.4 - $67.43 $79.8 Million - $116 Million	1,718,900 Added 22.93%	9,213,588 $514 Million
Q4 2019 Feb 06, 2020	BUY	$49.21 - $64.19 $98.1 Million - $128 Million	1,992,824 Added 36.22%	7,494,688 $481 Million
Q3 2019 Nov 12, 2019	BUY	$42.77 - $50.71 $3.47 Million - $4.12 Million	81,194 Added 1.5%	5,501,864 $279 Million
Q2 2019 Aug 02, 2019	SELL	$44.62 - $49.34 $5.36 Million - $5.93 Million	-120,100 Reduced 2.17%	5,420,670 $246 Million
Q1 2019 May 10, 2019	BUY	$45.12 - $53.8 $6.59 Million - $7.86 Million	146,100 Added 2.71%	5,540,770 $264 Million
Q4 2018 Feb 13, 2019	BUY	$48.76 - $63.23 $4.15 Million - $5.38 Million	85,100 Added 1.6%	5,394,670 $280 Million
Q3 2018 Nov 08, 2018	SELL	$55.19 - $62.25 $10 Million - $11.3 Million	-181,600 Reduced 3.31%	5,309,570 $330 Million
Q2 2018 Aug 09, 2018	BUY	$50.53 - $62.98 $7.4 Million - $9.23 Million	146,500 Added 2.74%	5,491,170 $304 Million
Q1 2018 May 04, 2018	SELL	$59.92 - $68.98 $47.2 Million - $54.3 Million	-787,700 Reduced 12.84%	5,344,670 $338 Million
Q4 2017 Feb 07, 2018	BUY	$59.94 - $65.35 $2.45 Million - $2.67 Million	40,900 Added 0.67%	6,132,370 $376 Million
Q3 2017 Nov 03, 2017	BUY	$55.23 - $63.74 $336 Million - $388 Million	6,091,470	6,091,470 $388 Million

Others Institutions Holding BMY

# of Institutions

2,428

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.

Account

Swiss National Bank Bristol Myers Squibb CO Transaction History